As of 2025-07-07, the Fair Value of Amarantus Bioscience Holdings Inc (AMBS) is -0.36 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Amarantus Bioscience Holdings Inc is -36,359,350.00%.
With the market price of 0.00 USD and our fair value calculation, Amarantus Bioscience Holdings Inc (AMBS) is not a good investment. Investing in AMBS stocks now will result in a potential loss of 36,359,350.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2013-12-31 | 2014-12-31 | 2015-12-31 | 2017-12-31 | 2018-12-31 | 5Y Avg | |
| Net income | -15.13 | -27.28 | -25.21 | -4.63 | -10.58 | -16.57 |
| YoY growth | -194.64% | -80.26% | 7.56% | 81.63% | -128.49% | -62.84% |
| Market Cap (mil) | 0.00 |
| P/E | |
| Forward P/E |
| EPS | -0.07 |
| Avg earnings growth rate | -62.84% |
| TTM earnings | -26.79 |